Diagnosticos da America S.A. (DASA3) Financial Statements
Diagnosticos da America S.A. Financial Overview
Diagnosticos da America S.A.'s market cap is currently $3.72B. The company's EPS TTM is $-0.71; its P/E ratio is -4.18; and it has a dividend yield of 0.70%. Diagnosticos da America S.A. is estimated to report earnings on November 5, 2026, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 11.17B | $ 15.32B | $ 14.25B | $ 13.13B | $ 10.42B |
| Gross Profit | $ 3.39B | $ 4.19B | $ 3.89B | $ 3.80B | $ 3.12B |
| Operating Income | $ 1.01B | $ 1.01B | $ 911.70M | $ 1.02B | $ 88.52M |
| EBITDA | $ 2.04B | $ 2.15B | $ 2.21B | $ 2.21B | $ 1.08B |
| Net Income | $ -1.15B | $ -1.20B | $ -1.17B | $ -386.92M | $ -226.57M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.67B | $ 1.90B | $ 1.69B | $ 3.08B | $ 3.61B |
| Total Assets | $ 18.56B | $ 26.46B | $ 26.21B | $ 26.84B | $ 23.25B |
| Total Debt | $ 8.84B | $ 12.99B | $ 13.29B | $ 13.90B | $ 9.77B |
| Net Debt | $ 6.18B | $ 11.25B | $ 11.71B | $ 12.62B | $ 8.62B |
| Total Liabilities | $ 11.67B | $ 18.52B | $ 18.88B | $ 19.75B | $ 15.70B |
| Stockholders' Equity | $ 6.87B | $ 7.93B | $ 7.33B | $ 7.08B | $ 7.54B |
| Cash Flow | |||||
| Free Cash Flow | $ -326.65M | $ -510.55M | $ -1.77B | $ -1.17B | $ 392.37M |
| Operating Cash Flow | $ -36.35M | $ 27.95M | $ -963.62M | $ -29.00M | $ 1.30B |
| Investing Cash Flow | $ 1.35B | $ -373.59M | $ 978.96M | $ -1.60B | $ -4.95B |
| Financing Cash Flow | $ -392.98M | $ 503.21M | $ 284.87M | $ 1.77B | $ 4.04B |
Currency in BRL